tirzepatide hims Zepbound® KwikPen® How we're expanding access to

According to the 2024 American Diabetes Association Standards of Care, GLP-1 receptor agonists have become first line pharmacotherapy for most patients with type 2 diabetes mellitus (T2DM), including those with concomitant atherosclerotic cardiovascular disease (ASCVD), indicators of high ASCVD risk, or chronic kidney disease

You guys Rock

Drawing from his foundation and board certification in Family Medicine, he developed the innovative medical principles behind the Blue Sky MD concept of total patient care

Medical conditions like anaemia, hypothyroidism and polycystic ovarian syndrome can also increase pigmentation

This would have allowed for a comparison between each intervention individually and then a combination of both treatments